Causes	causes	O	O	O	O
of	of	O	O	O	O
acute	acute	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
receiving	receiving	O	O	O	O
kidney	kidney	O	O	O	O
transplantation	transplantation	O	O	O	O
.	.	O	O	O	O

OBJECTIVES	objectives	O	O	O	O
:	:	O	O	O	O
Thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
is	is	O	O	O	O
a	a	O	O	O	O
well-known	well-known	O	O	O	O
problem	problem	O	O	O	O
in	in	O	O	O	O
patients	patients	O	O	O	O
following	following	O	O	O	O
renal	renal	O	O	O	O
transplantation	transplantation	O	O	O	O
.	.	O	O	O	O

In	in	O	O	O	O
postrenal	postrenal	O	O	O	O
transplantation	transplantation	O	O	O	O
,	,	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
is	is	O	O	O	O
often	often	O	O	O	O
a	a	O	O	O	O
reflection	reflection	O	O	O	O
of	of	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
uremic	uremic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
.	.	O	O	O	O

We	we	O	O	O	O
aimed	aimed	O	O	O	O
to	to	O	O	O	O
determine	determine	O	O	O	O
the	the	O	O	O	O
causes	causes	O	O	O	O
of	of	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
population	population	O	O	O	O
of	of	O	O	O	O
renal	renal	O	O	O	O
transplantation	transplantation	O	O	O	O
recipients	recipients	O	O	O	O
and	and	O	O	O	O
discuss	discuss	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
.	.	O	O	O	O

MATERIALS	materials	O	O	O	O
AND	and	O	O	O	O
METHODS	methods	O	O	O	O
:	:	O	O	O	O
We	we	O	O	O	O
investigated	investigated	O	O	O	O
the	the	O	O	O	O
causes	causes	O	O	O	O
of	of	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
during	during	O	O	O	O
a	a	O	O	O	O
1-year	1-year	O	O	O	O
period	period	O	O	O	O
,	,	O	O	O	O
from	from	O	O	O	O
June	june	O	O	O	O
2003	2003	O	O	O	O
to	to	O	O	O	O
June	june	O	O	O	O
2004	2004	O	O	O	O
,	,	O	O	O	O
at	at	O	O	O	O
the	the	O	O	O	O
King	king	O	O	O	O
Fahad	fahad	O	O	O	O
National	national	O	O	O	O
Guard	guard	O	O	O	O
Hospital	hospital	O	O	O	O
in	in	O	O	O	O
Riyadh	riyadh	O	O	O	O
,	,	O	O	O	O
Saudi	saudi	O	O	O	O
Arabia	arabia	O	O	O	O
,	,	O	O	O	O
by	by	O	O	O	O
reviewing	reviewing	O	O	O	O
the	the	O	O	O	O
slides	slides	O	O	O	O
of	of	O	O	O	O
all	all	O	O	O	O
transplant	transplant	O	O	O	O
biopsies	biopsies	O	O	O	O
(	(	O	O	O	O
n=25	n=25	O	O	O	O
)	)	O	O	O	O
performed	performed	O	O	O	O
during	during	O	O	O	O
this	this	O	O	O	O
interval	interval	O	O	O	O
.	.	O	O	O	O

Pre-	pre-	O	O	O	O
and	and	O	O	O	O
posttransplant	posttransplant	O	O	O	O
crossmatching	crossmatching	O	O	O	O
was	was	O	O	O	O
done	done	O	O	O	O
when	when	O	O	O	O
possible	possible	O	O	O	O
.	.	O	O	O	O

RESULTS	results	O	O	O	O
:	:	O	O	O	O
Five	five	O	O	O	O
cases	cases	O	O	O	O
of	of	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
were	were	O	O	O	O
found	found	O	O	O	O
.	.	O	O	O	O

Three	three	O	O	O	O
of	of	O	O	O	O
these	these	O	O	O	O
cases	cases	O	O	O	O
were	were	O	O	O	O
from	from	O	O	O	O
the	the	O	O	O	O
25	25	O	O	O	O
transplantations	transplantations	O	O	O	O
performed	performed	O	O	O	O
at	at	O	O	O	O
King	king	O	O	O	O
Fahad	fahad	O	O	O	O
National	national	O	O	O	O
Guard	guard	O	O	O	O
Hospital	hospital	O	O	O	O
,	,	O	O	O	O
while	while	O	O	O	O
the	the	O	O	O	O
other	other	O	O	O	O
2	2	O	O	O	O
transplantations	transplantations	O	O	O	O
had	had	O	O	O	O
been	been	O	O	O	O
performed	performed	O	O	O	O
abroad	abroad	O	O	O	O
and	and	O	O	O	O
were	were	O	O	O	O
referred	referred	O	O	O	O
to	to	O	O	O	O
us	us	O	O	O	O
for	for	O	O	O	O
follow-up	follow-up	O	O	O	O
.	.	O	O	O	O

Three	three	O	O	O	O
cases	cases	O	O	O	O
were	were	O	O	O	O
related	related	O	O	O	O
to	to	O	O	O	O
cyclosporine	cyclosporine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
and	and	O	O	O	O
1	1	O	O	O	O
case	case	O	O	O	O
was	was	O	O	O	O
secondary	secondary	O	O	O	O
to	to	O	O	O	O
both	both	O	O	O	O
cyclosporine	cyclosporine	CHEMICALS	O	OTHERS	I
and	and	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

The	the	O	O	O	O
fifth	fifth	O	O	O	O
case	case	O	O	O	O
had	had	O	O	O	O
features	features	O	O	O	O
of	of	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
related	related	O	O	O	O
to	to	O	O	O	O
an	an	O	O	O	O
antiphospholipid	antiphospholipid	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
in	in	O	O	O	O
a	a	O	O	O	O
patient	patient	O	O	O	O
with	with	O	O	O	O
systemic	systemic	O	O	OTHERS	I
lupus	lupus	O	O	OTHERS	I
erythematosus	erythematosus	O	O	OTHERS	I
.	.	O	O	O	O

CONCLUSIONS	conclusions	O	O	O	O
:	:	O	O	O	O
In	in	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
most-frequent	most-frequent	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
uremic	uremic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
in	in	O	O	O	O
patients	patients	O	O	O	O
following	following	O	O	O	O
renal	renal	O	O	O	O
transplantation	transplantation	O	O	O	O
is	is	O	O	O	O
recurrence	recurrence	O	O	O	O
of	of	O	O	O	O
the	the	O	O	O	O
hemolytic	hemolytic	O	DISEASE	OTHERS	I
uremic	uremic	O	DISEASE	OTHERS	I
syndrome	syndrome	O	DISEASE	OTHERS	I
.	.	O	O	O	O

Other	other	O	O	O	O
causes	causes	O	O	O	O
include	include	O	O	O	O
drug-related	drug-related	O	O	O	O
(	(	O	O	O	O
cyclosporine	cyclosporine	CHEMICALS	O	OTHERS	I
,	,	O	O	O	O
tacrolimus	tacrolimus	CHEMICALS	O	OTHERS	I
)	)	O	O	O	O
toxicity	toxicity	O	DISEASE	OTHERS	I
,	,	O	O	O	O
procoagulant	procoagulant	O	O	O	O
status	status	O	O	O	O
,	,	O	O	O	O
and	and	O	O	O	O
antibody-mediated	antibody-mediated	O	O	O	O
rejection	rejection	O	O	O	O
.	.	O	O	O	O

We	we	O	O	O	O
found	found	O	O	O	O
that	that	O	O	O	O
the	the	O	O	O	O
most-frequent	most-frequent	O	O	O	O
cause	cause	O	O	O	O
of	of	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
was	was	O	O	O	O
drug	drug	O	O	O	O
related	related	O	O	O	O
,	,	O	O	O	O
secondary	secondary	O	O	O	O
mainly	mainly	O	O	O	O
to	to	O	O	O	O
cyclosporine	cyclosporine	CHEMICALS	O	OTHERS	I
.	.	O	O	O	O

In	in	O	O	O	O
the	the	O	O	O	O
current	current	O	O	O	O
study	study	O	O	O	O
,	,	O	O	O	O
the	the	O	O	O	O
frequency	frequency	O	O	O	O
of	of	O	O	O	O
thrombotic	thrombotic	O	DISEASE	OTHERS	I
microangiopathy	microangiopathy	O	DISEASE	OTHERS	I
was	was	O	O	O	O
similar	similar	O	O	O	O
to	to	O	O	O	O
the	the	O	O	O	O
percentage	percentage	O	O	O	O
reported	reported	O	O	O	O
in	in	O	O	O	O
the	the	O	O	O	O
literature	literature	O	O	O	O
(	(	O	O	O	O
20	20	O	O	O	O
%	%	O	O	O	O
)	)	O	O	O	O
.	.	O	O	O	O

